Medicare Group Q.P.S.C. (QSE:MCGS)
| Market Cap | 1.80B |
| Revenue (ttm) | 517.17M |
| Net Income (ttm) | 86.10M |
| Shares Out | 281.44M |
| EPS (ttm) | 0.31 |
| PE Ratio | 20.89 |
| Forward PE | 11.96 |
| Dividend | 0.20 (3.09%) |
| Ex-Dividend Date | Apr 17, 2025 |
| Volume | 256,701 |
| Average Volume | 752,673 |
| Open | 6.40 |
| Previous Close | 6.40 |
| Day's Range | 6.38 - 6.46 |
| 52-Week Range | 4.22 - 7.21 |
| Beta | 0.28 |
| RSI | 46.83 |
| Earnings Date | Feb 24, 2026 |
About Medicare Group Q.P.S.C.
Medicare Group Q.P.S.C. provides healthcare and treatment services in Qatar. The company operates hospitals, medical clinic centers, and outpatient clinics. The company was formerly known as Al Ahli Specialized Hospital Company Q.S.C. The company was founded in 1995 and is based in Doha, Qatar. [Read more]
Financial Performance
In 2024, Medicare Group Q.P.S.C.'s revenue was 523.49 million, an increase of 7.72% compared to the previous year's 485.96 million. Earnings were 60.06 million, a decrease of -8.59%.
Financial StatementsNews
Why Medicare price negotiations matter for Novo Nordisk, AstraZeneca, and other European pharma companies
Pharma companies are facing pricing pressure from several directions, including from the U.S. Medicare negotiations
Medicare 2027 IRA drug prices average 36% net discount
CNBC’s Bertha Coombs reports on Medicare’s 2027 IRA drug price.
Trump administration unveils Medicare negotiated price cuts for 15 drugs, including Ozempic
The Trump administration late Tuesday announced new lower Medicare prices for 15 drugs that were part of the latest round of the program's price negotiations, touting a total of $12 billion saved comp...
Nordisk Rises After Medicare Slashes GLP-1 Prices
Nordisk Rises After Medicare Slashes GLP-1 Prices
Medicare Slashes Ozempic's Price Tag 71%; Why Novo Nordisk Rallied
Novo Nordisk stock jumped Wednesday on a lighter-than-feared discount for Ozempic and Wegovy under the Inflation Reduction Act.
After years of rising drug prices, more discounts are here — at least for Medicare
Price are falling sharply for Medicare beneficiaries prescribed Novo Nordisk’s GLP-1 drugs like Ozempic in 2027.
CMS Unveils 2027 Rule To Refocus Medicare Advantage On Outcomes
The U.S. Centers for Medicare & Medicaid Services (CMS) proposed rule changes for the 2027 Medicare Advantage and Part D contract year. The goal is to refine plan performance metrics and simplify enro...
Medicare Announces Price Cuts For 15 Drugs— Novo Nordisk's Wegovy And Ozempic To Cost $274 A Month
The U.S. Centers for Medicare and Medicaid Services (CMS) on Tuesday announced that it has secured lower prices for 15 of its highest‑cost medications, resulting in substantial annual savings on presc...
Eli Lilly (LLY) Set to Gain as Medicare Negotiates Discounts on Competitor Drugs
Eli Lilly (LLY) Set to Gain as Medicare Negotiates Discounts on Competitor Drugs
Medicare Open Enrollment Ends Soon. 3 Moves to Make Before It’s Over
Healthcare tends to be a major expense for retirees, and the right Medicare plan could spell the difference between paying less or paying more. That’s why it’s so important to take advantage of Medica...
Medicare Just Announced Its 2026 Premiums, and It's Bad News for Social Security's Dual Enrollees
No silver lining awaits Social Security beneficiaries enrolled in traditional Medicare in the new year.
What Every Retiree Should Know About Medicare vs. Medigap
If you don't buy a Medigap plan at the best time, it could cost you a lot.
Medicare’s telehealth services will be extended until Jan. 30 if shutdown ends
Medicare’s telehealth services are set to resume under the agreement to reopen the government, bringing back the pandemic-era service that allows doctors to conduct about 5% of Medicare’s overall outp...
Millions more Americans could access obesity drugs after Trump's deals with Eli Lilly, Novo Nordisk
Medicare will start covering obesity drugs for the first time, which could open access to millions of seniors and spur more private insurers to follow suit.
Medicare to Cover GLP-1 Drugs for as Little as $50 a Month Under Trump Plan
Seniors could soon pay just $50 a month for Ozempic and other drugs used for weight loss under a new Trump plan to cut prescription costs.
Eli Lilly, Novo Nordisk Make Weight-Loss Drugs More Affordable Via Medicare, Medicaid, TrumpRx
President Donald Trump on Thursday announced agreements with Eli Lilly and Co. (NYSE: LLY) and Novo Nordisk A/S (NYSE: NVO) to significantly reduce prices for their GLP-1-based obesity and diabetes ...
Medicare staffing raises alarm with open enrollment underway
Health policy experts on Tuesday urged the Centers for Medicare and Medicaid Services (CMS) to boost staffing, noting that the government shutdown has only hindered services. This staffing shortage co...
Centene And Oscar Health Stocks Sink After Molina Warning
U.S. healthcare insurance providers Centene Corporation (NYSE: CNC) and Oscar Health Inc. (NYSE: OSCR) stock are trading lower as their peer Molina Healthcare Inc. (NYSE: MOH) reported disappointin...
Medicare to recall thousands of furloughed workers during open-enrollment season
The Centers for Medicare and Medicaid Services has had some technical difficulties during the government shutdown.
Glaukos falls as Medicare administrator contractors meeting draws concern
Your Medicare Coverage Will Continue During the Shutdown--But Some Services May Not
The shutdown continues, but Medicare is mostly safe from cuts and service lapses.
Dave Ramsey, AARP raise red flag on Medicare; changes coming soon
The Annual Enrollment Period (AEP) for Medicare, which runs from Oct. 15 to Dec. 7, is the designated time for individuals already enrolled in Medicare to
TLC Insurance Group and Nomo Smart Care™ Announce Strategic Partnership to Support Medicare-Eligible Seniors and Their Families
MINNEAPOLIS , Oct. 10, 2025 /PRNewswire/ -- TLC Insurance Group and Nomo Smart Care™ today announced a strategic partnership designed to give Medicare-eligible seniors and their families the guidance ...
Novo Nordisk’s appeal to halt Medicare price negotiations rejected
Dave Ramsey warns Americans on critical Medicare problem
The personal finance radio host sounds the alarm as Medicare's Annual Enrollment Period draws near.